There are no current published guidelines in the English language psychiatric literature that discuss treatment for BD. A 2019 case of BD from GHU Paris treated the patient with largactil (chlorpromazine). Assuming that BPD is an equivalent diagnosis, treatment depends on the severity of the episode. Mildly affected patients may receive supportive management and observation with additional outpatient therapy. More severe illness may require inpatient hospitalization and pharmacologic treatment with benzodiazepines and/or antipsychotic medication, for example: risperidone, though no clinical trials have examined the efficacy of therapy for BPD.
Bouffée délirante
Ugeskrift for Læger
Self-surgery
Revue Médicale de Bruxelles
Mary de Lourdes Gogan
Souffle 
Revista Cubana de Cirugía
Sanatorium